drugset / Trial / NCT04107077
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
To assess if PD-L1 expression can be upregulated in peritoneal metastases from gastric cancer after the administration of HIPEC with greater frequency compared to systemic chemotherapy alone
Timeline
- Start
- 2025-09-09
- Primary completion
- 2030-06-01
- Completion
- 2030-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 200 mg | — |
| Subject | Mitomycin C | Other / unclassified | 30 mg | — |